DOACs

DRUG2 trials

Sponsors

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions

Atrial FibrillationMyeloproliferative NeoplasmThromboembolism, Venous

Unknown Phase

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms

CompletedNCT04192916

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETSMyeloproliferative Neoplasm

Start: 2019-09-01End: 2020-12-31Updated: 2021-02-21

DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers

Active, not recruitingNCT05750680

Fondazione Policlinico Universitario Agostino Gemelli IRCCSAtrial Fibrillation, Thromboembolism, Venous

Start: 2021-05-13End: 2025-05-01Target: 23Updated: 2025-02-27